Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Consideration of QT/QTc interval data in a phase I study in patients with advanced cancer.

× No keyword cloud information.

5 in total

Review 1. Targeted Cancer Therapies and QT Interval Prolongation: Unveiling the Mechanisms Underlying Arrhythmic Complications and the Need for Risk Stratification Strategies.

Authors: Rezarta Cuni; Iris Parrini; Riccardo Asteggiano; Maria Rosa Conte
Journal: Clin Drug Investig Date: 2017-02 Impact factor: 2.859

Review 2. Cancer chemotherapy and cardiac arrhythmias: a review.

Authors: Juan Tamargo; Ricardo Caballero; Eva Delpón
Journal: Drug Saf Date: 2015-02 Impact factor: 5.606

Review 3. Safety biomarkers and the clinical development of oncology therapeutics: considerations for cardiovascular safety and risk management.

Authors: Howard Fingert; Mary Varterasian
Journal: AAPS J Date: 2006-03-10 Impact factor: 4.009

4. Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials.

Authors: Mitesh J Borad; Arundhati D Soman; Martin Benjamin; Daniel Casa; Waibhav D Tembe; Barbara F Piper; Ramesh Ramanathan; Raoul Tibes; Gayle Jameson; Karen Ansaldo; Daniel D Von Hoff
Journal: Invest New Drugs Date: 2012-12-16 Impact factor: 3.850

5. Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies.

Authors: Priscila H Goncalves; Francine High; Paul Juniewicz; Gareth Shackleton; Jing Li; Scott Boerner; Patricia M LoRusso
Journal: Invest New Drugs Date: 2008-05-01 Impact factor: 3.850

5 in total